DECHRA PHARMACEUTICA

DPH
Delayed Quote. Delayed  - 05/26 11:35:18 am
3552GBX +1.78%

Turn to zoom
Prev.3552.0000
Open3502.0000
High3552.0000
Low3456.0000
Volume152 582
Latest news
05/17
04/26
04/08
03/03
Chart DECHRA PHARMACEUTICALS PLC
Technical analysis trends
Short TermMid-TermLong Term
TrendBearishBearishBearish
Resistance3 6384 2724 272
Spread/Res.-4,9%-19%-19%
Spread/Supp.10,0%10,0%6,4%
Support3 1483 1483 254
Financials
Sales 2022 664 M 834 M 834 M
Net income 2022 77,0 M 96,7 M 96,7 M
Net Debt 2022 162 M 204 M 204 M
P/E ratio 2022 51,3x
Yield 2022 1,26%
Capitalization 3 783 M 4 750 M 4 750 M
EV / Sales 2022 5,94x
EV / Sales 2023 5,39x
Nbr of Employees -
Free-Float 98,6%
Company
Dechra Pharmaceuticals PLC is engaged in veterinary pharmaceuticals and related products business. The Company is engaged in development, manufacture and marketing of products for veterinarians. Its segments include European Pharmaceuticals, North American (NA) Pharmaceuticals and Pharmaceuticals...

>> Read more
Sector :
Veterinary Drugs
Calendar :
2022-09-05 Earnings Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 10
Last Close Price 3 490,00 GBX
Average target price 4 842,70 GBX
Spread / Average Target 38,8%